ENTITY
Celgene Corp

Celgene Corp (CELG US)

77
Analysis
Health CareUnited States
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
more
Refresh
27 Jan 2019 09:18

Last Week in Event SPACE: Renault/Nissan, Bank Danamon, Kabu, Celgene, Intouch

Last Week in Event SPACE ... The eventual unwind of tension may involve an increase in Nissan Motor (7201 JP)'s stake in Renault SA (RNO FP) and a...

Logo
903 Views
Share
bullishCelgene Corp
25 Jan 2019 11:14

Bristol-Myers Beats the Drum for Celgene in 4Q18 Earnings Call

Bristol Myers Squibb Co (BMY US) announced earnings for 4Q18 this morning followed by a conference call. Most metrics beat street expectations but...

Logo
1k Views
Share
25 Jan 2019 08:40Syndicated

Bristol Myers Squib – Reaffirming Its View on Celgene Corp

The management of Bristol Myers Squibb Co (BMY US) reiterated its optimistic view regarding the acquisition of Celgene Corp (CELG US) on its Q4-18...

Logo
514 Views
Share
bullishXiaomi Corp
20 Jan 2019 09:16

Last Week in Event SPACE: Xiaomi, NTT, Capitaland, Panalpina, Celgene/Bristol Myers, Amorepacific

Last Week in Event SPACE ... Do not buy Xiaomi Corp (1810 HK) as there is a LOT of overhang still to come.  Indications are a total of ¥550-650bn...

Logo
984 Views
Share
18 Jan 2019 11:41Syndicated

Celgene and Bristol-Myers Squibb – Undervalued and Underappreciated

A dismal 2018 for the pharmaceutical and bio-tech stocks seems far in the rear view mirror. 2019 began with a bang with two blockbuster deals in...

Logo
669 Views
Share
x